Williams Jones Wealth Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Williams Jones Wealth Management’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$866	–	565
2023 Q3	$866	Hold	10,000	–	–	﹤0.01%	547
2023 Q2	$5.6K	Hold	10,000	–	–	﹤0.01%	524
2023 Q1	$11.4K	Hold	10,000	–	–	﹤0.01%	558
2022 Q4	$11.2K	Hold	10,000	–	–	﹤0.01%	551
2022 Q3	$21K	Hold	10,000	–	–	﹤0.01%	561
2022 Q2	$14K	Hold	10,000	–	–	﹤0.01%	565
2022 Q1	$17K	Buy	+10,000	New	+$14.3K	﹤0.01%	521

Other funds holding RVLP

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Williams Jones Wealth Management's RVLP Position: Q4 2023 in Review

Williams Jones Wealth Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 10,000 shares — an estimated $866 sold.

Williams Jones Wealth Management first reported a position in RVLP in Q1 2022 and held it in 7 quarters. The position peaked at $21K in Q3 2022. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

Williams Jones Wealth Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Williams Jones Wealth Management sold 10,000 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $866.
Williams Jones Wealth Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2022 and held it in 7 quarters.
Williams Jones Wealth Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $21K in Q3 2022.
3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Williams Jones Wealth Management's 13F filing for Q4 2023, filed 14 Feb 2024.